loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

GOLDLINE PHARMACEUTICAL IPO

CLOSED

IPO Details

12th May 2026
14th May 2026
3,000
₹ 246,000
₹ 41-43
₹ 12 Crore

Issue timeline

  • 12-14 May 2026
  • 15-May-2026
  • 18-May-2026
  • 18-May-2026
  • 19-May-2026

Subscription Status

Shareholder -
Qualified Institutional Buyers -
Non-Institutional Investor -
Retail Individual Investor -
Employee -
Total -

About Company

Goldline Pharmaceutical was incorporated on August 02, 2004. The company markets pharmaceutical products under the “Goldline” brand across five segments, including pharma, wellness, and ayurvedic categories. Its products are manufactured through third-party partners based on the company’s specifications, market research, and quality standards
-
Name Designation
Amol Laxmikant Mujumdar Chairman & Managing Director
Swapan Premprakash Khandelwal Whole-Time Director
Prashant Shrikrishna Karkare Executive Director
Avinash Pandurang Ambulkar Executive Director
Prashant Vithalrao Rahate Non-Executive Director
Mehul Hari Ranade Independent Director
Renuka Saurabh Borole Independent Director
Shraddha Kiran Kulkarni Independent Director

Objectives

Prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company
General corporate purposes

Strengths & Risks

Strengths (2)

The company follows an asset-light business model by sourcing products through manufacturing partners instead of investing in its own production facilities. This approach enhances capital efficiency, supports scalable growth, improves cash flow management, and reduces operational risk

Risks (3)

The company’s operations require substantial working capital, primarily for inventory and trade receivables, making efficient cash flow management critical. Any inability to secure sufficient funding or delays in customer payments could adversely impact its operations and financial performance

Financials

Frequently Asked Questions

Who are the promoters of Goldline Pharmaceutical Ltd.?

The promoters of the company are Amol Laxmikant Mujumdar and Swapan Premprakash Khandelwal.

The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.

The price band of the IPO is Rs 41.0 - 43.0.

The IPO application opens on May 12, 2026 and closes on May 14, 2026.

The minimum lot size for the IPO is 6000. The maximum lot size for the IPO is 6000.

View More

*The financials mentioned above are sourced from DRHP/ RHP documents.